跳至主要内容
临床试验/NCT07150559
NCT07150559招募中不适用

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection: Study Protocol for a Multicenter, Three-arm, Open-label, Randomized, Parallel-controlled Trial

Beijing Anzhen Hospital1 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2026年2月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
306
试验地点
1
主要终点
Major adverse events

研究概览

简要总结

The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease;
  • Adult patients (18-70 years) weighing 50-120 kg;
  • Time interval between the onset of symptoms and operation is less than 14 days;
  • Indications for total aortic arch replacement are available;
  • Signed informed consent and availability for follow-up.

排除标准

  • History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency;
  • Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction;
  • History of severe cerebral infarction (with cerebral infarction sequels);
  • Preoperative intubation or unconsciousness;
  • Inflammatory aortic diseases, such as Takayasu arteritis and Behçet's disease, etc;
  • History of infectious aortic diseases;
  • History of cardiac and aortic surgery;
  • History of malignancy or previous radiotherapy;
  • Pregnant or feeding women, or anyone planning to reproduce during the test period;
  • Without an informed consent signature;
  • Participating in any other clinical trial;
  • Having other causes not eligible for operation.

研究组 & 干预措施

Arch-clamping under mild hypothermia

Experimental

TAR + FET procedure is performed using arch-clamping technique under mild hypothermia.

干预措施: Arch-Clamping Technique under Mild Hypothermia (Procedure)

Arch-clamping under moderate hypothermia

Experimental

TAR + FET procedure is performed using arch-clamping technique under moderate hypothermia.

干预措施: Arch-Clamping Technique under Moderate Hypothermia (Procedure)

Sun's procedure using bACP

Active Comparator

Total arch replacement and frozen elephant trunk implantation with moderate hypothermic circulatory arrest.

干预措施: Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest (Procedure)

结局指标

主要结局

Major adverse events

时间窗: Thirty days and 12 months after the operation

Major adverse events include death, renal replacement therapy, stroke, and paraplegia

次要结局

  • Mechanical ventilation time(Discharge / 30 days after operation)
  • The length of ICU stay(Discharge / 30 days after operation)
  • Circulatory arrest time(During surgery)
  • Cardiopulmonary bypass time(During surgery)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Junming Zhu

Vice Chairman, Aortic Surgery Committee of Chinese Association of Cardiovascular Surgeons; President, Beijing Society for Thoracic and Cardiovascular Surgery; Director, Center for Aortic Surgery, Beijing Anzhen Hospital

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验